Advertisement

Clinical Trial of Sisomycin: Evaluation of Two Different Dosages

  • M. Jonsson
  • E. Bengtsson
  • S. Jonsson
  • I. Julander
  • G. Tunevall
Part of the Chemotherapy book series (CT, volume 2)

Abstract

Sisomicin is a new aminoglycoside antibiotic structurally related to gentamicin. From data in the literature it is known that the antimicrobial activity of sisomicin is similar to that of gentamicin. However, sisomicin has been reported to have advantageous characteristics, e.g. higher activity against certain bacterial species, effectivity against strains resistant to gentamicin and also a higher bactericidal effect in the presence of serum. These data qualified the drug for a clinical trial. The main purpose of the study was to investigate the pharmacokinetics at two different dose regimens in patients with normal and impaired renal function.

Keywords

Creatinine Clearance Normal Renal Function Impaired Renal Function Aminoglycoside Antibiotic Pyelonephritis Acuta 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer Science+Business Media New York 1976

Authors and Affiliations

  • M. Jonsson
    • 1
  • E. Bengtsson
    • 1
  • S. Jonsson
    • 1
  • I. Julander
    • 1
  • G. Tunevall
    • 1
  1. 1.Roslagstull Hospital; Karolinska InstituteUniversity of Lund Roslagstull; StockholmLund.Sweden

Personalised recommendations